Zu den Navigationen / Inhalt überspringen Zum Inhalt / Navigationen überspringen
Biologie
Startseite
Kontakt
Impressum
Beteiligte Wissenschaftler:
Veröffentlichungen:
Wülfing, P.; Kersting, C.; Tio, J.; Fischer R.J., Wulfing C., Poremba C., Diallo R., Bocker W., Kiesel L. Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. CLINICAL CANCER RESEARCH, 10 (7): 2393-2400 (2004)
Kainulainen, V., Götte, M., Reizes, O. , Elenius, K., Bernfield, M. Inhibition by the soluble syndecan-1 ectodomain delays wound healing in syndecan-1 overexpressing mice JOURNAL OF BIOLOGICAL CHEMISTRY 279, 40: 41928-41935 (2004)
Ledin, J., Staatz, W., Li, J.-P., Götte, M., Selleck, S., Kjellén, L., Spillmann, D. Heparan sulfate structure in mice with genetically modified heparan sulfate production JOURNAL OF BIOLOGICAL CHEMISTRY 279, 42732-42741 (2004)
Di Leo, A.; Chan, S.; Paesmans, M.; Friedrichs K., Pinter T., Cocquyt V., Murray E., Bodrogi I., Walpole E., Lesperance B., Korec S., Crown J., Simmonds P., Von Minckwitz G., Leroy J.Y. Durbecq V., Isola J., Aapro M., Piccart M.J., Larsimont D. HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel BREAST CANCER RESEARCH AND TREATMENT, 86 (3): 197-206 (2004)
Wülfing, P.; Diallo, R.; Kersting, C.; Wülfing C., Poremba C., Greb R.R., Bocker W., Kiesel L. Endothelin-1, endothelin-A- and endothelin-B-receptor expression in preinvasive and invasive breast disease ONCOLOGY REPORTS, 11 (4): 791-796 (2004)
Rody A., Diallo R., Poremba C., Speich R., Wuelfing P., Kissler S., Solbach C., Kiesel L., Jackisch C. Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast. ONCOLOGY REPORTS 12(4):695-9 (2004)
Wülfing, C.; Eltze, E.; von Struensee, D.; Wuüfing P., Hertle L., Piechota H. Cyclooxygenase-2 expression in bladder cancer: Correlation with poor outcome after chemotherapy EUROPEAN UROLOGY, 45 (1): 46-52 (2004)
Wülfing C., Eltze E., von Struensee D., Wülfing P., Bode M.E., Bettendorf O., Piechota H.J., Hertle L. Cyclooxygenase-2 Expression beim Harnblasenkarzinom: Tumorbiologische und klinische Bedeutung. AKTUELL UROL; 35:331-8. (2004)
Wülfing P., Diallo R., Kersting C., Wülfing C., Poremba C., Rody A., Greb R.R., Bocker W., Kiesel L. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up CLINICAL CANCER RESEARCH 9 (11): 4125-4131 (2003)
du Bois A., Luck H.J., Meier W., et al. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer JOURNAL OF THE NATIONAL CANCER INSTITUTE 95 (17): 1320-1330 (2003)
Garritsen H.S.P., Brune T., Louwen F., Wullenweber J., Ahlke C., Cassens U., Witteler R., Sibrowski W. Autologous red cells derived from cord blood: collection, preparation, storage and quality controls with optimal additive storage medium (Sag-mannitol) TRANSFUSION MEDICINE 13 (5): 303-310 (2003)
Wulfing P., Diallo R., Muller C., Wulfing C., Poremba C., Heinecke A., Rody A., Greb R.R., Bocker W. Kiesel L. Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 129 (7): 375-382 (2003)
Jackisch C., Jaber M., Burkamp U., et al. Maintenance of dose intensity in adjuvant chemotherapy of breast cancer in patients treated outside a clinical trial - Results of a retrospective study GEBURTSHILFE UND FRAUENHEILKUNDE 63 (4): 333-341 (2003)
Baez E., Huber A.,Vetter M., et al. Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided mammotome vacuum device ULTRASOUND IN OBSTETRICS & GYNECOLOGY 21 (3): 267-272 (2003)
Stute, P.; Soukup, J.; Menzel, M.; Sabatowski R., Grond S. Analysis and treatment of different types of neuropathic cancer pain JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 26 (6): 1123-1131 (2003)
Diallo, R.; Schaefer, K.L.; Bankfalvi, A.; Decker T., Ruhnke M., Wülfing P., Jackisch C., Luttges J. Sorensen P.H., Singh M., Poremba C. Secretory carcinoma of the breast: A distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry HUMAN PATHOLOGY, 34 (12): 1299-1305 (2003)
Zurückblättern
Diese Seite:
© 2005 Universität Münster - Dezernat 6.3. + Forschungsberichte
Seitenanfang
© Universität Münster Schlossplatz 2 · 48149 Münster Tel.: +49 251 83-0 · Fax: +49 (251) 83-3 20 90 E-Mail: verwaltung@uni-muenster.de